Citations

Showing 10 of 108119 citations.

Polygenic Risk Scores That Predict Common Diseases Using Millions of Single Nucleotide Polymorphisms: Is More, Better?
Cecile, A, Janssens, A. Cecile J.W. , Joyner, Michael J.

Mayo Clinic

Clinical Chemistry | February 26, 2019 | Volume: 65 | Issue: 5 | Pages: 609-611

10.1373/clinchem.2018.296103 | PMID 30808642 Get It

Embolization of a large lumbar type A epidural arteriovenous fistula
Rinaldo, Lorenzo , Cloft, Harry J. , Rangel-Castilla, Leonardo , Lanzino, Giuseppe , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: Suppl_1 | Pages: V6

10.3171/2019.1.focusvid.18435 | PMID 30611177 Get It

Nuances of carotid artery stenting under flow arrest with dual-balloon guide catheter
Vercelli, Giovanni , Sorenson, Thomas J. , Giordan, Enrico , Rangel-Castilla, Leonardo , Lanzino, Giuseppe , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: Suppl_1 | Pages: V4

10.3171/2019.1.focusvid.18417 | PMID 30611184 Get It

Cerebral protection device utilization during carotid artery stenting (CAS) has been demonstrated to decrease the risk of perioperative stroke. The ProximAl Protection with the MO.MA Device During CaRotid Stenting (ARMOUR) Trial had the lowest event rates of any independently adjudicated study. In this video of two cases of severe carotid artery stenosis, the authors present the nuances of the CAS procedure utilizing a dual-balloon guide catheter device (MO.MA). This device has the benefit of being in place before the lesion is crossed with any device, being able to arrest flow while the atherosclerotic lesion is crossed, and aiding in protection from distal emboli and stroke. The video can be found here: https://youtu.be/0o8DlC1n6_M .
Transvenous embolization of thalamic arteriovenous malformation under transient cardiac standstill
Rangel-Castilla, Leonardo , Shallwani, Hussain , Siddiqui, Adnan H. , Siddiqui, Adnan H , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: Suppl_1 | Pages: V10

10.3171/2019.1.focusvid.18416 | PMID 30611173 Get It

Transvenous embolization (TE) has been increasingly applied for arteriovenous malformation (AVM) treatment. Transient cardiac standstill (TCS) has been described in cerebrovascular surgery but is uncommon for endovascular embolization. The authors present a patient with a ruptured thalamic AVM in whom both techniques were applied simultaneously. Surgery was considered, but the patient refused. Transarterial embolization was performed with an incomplete result. The deep-seated draining vein provided sole access to the AVM. A microcatheter was advanced into the draining vein. Under TCS, achieved with rapid ventricular pacing, complete AVM embolization was obtained. One-year magnetic resonance imaging and cerebral angiography demonstrated no residual AVM. The video can be found here: https://youtu.be/CAzb9md_xBU .
Novel rodent model for simulation of sylvian fissure dissection and cerebrovascular bypass under subarachnoid hemorrhage conditions: technical note and timing study
Perry, Avital , Graffeo, Christopher S. , Anding, William J., Link, Michael J., Rangel-Castilla, Leonardo , Carlstrom, Lucas P. , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: 2 | Pages: E17

10.3171/2018.11.focus18533 | PMID 30717047 Get It

OBJECTIVE Sylvian fissure dissection following subarachnoid hemorrhage (SAH) is a challenging but fundamental skill in microneurosurgery, and one that has become increasingly difficult to develop during residency, given the overarching management trends. The authors describe a novel rodent model for simulation of sylvian fissure dissection and cerebrovascular bypass under SAH conditions. METHODS A standardized microvascular anastomosis model comprising rat femoral arteries and veins was used for the experimental framework. In the experimental protocol, following exposure and skeletonization of the vessels, extensive, superficial (1- to 2-mm) soft-tissue debridement was conducted and followed by wound closure and delayed reexploration at intervals of 7, 14, and 28 days. Two residents dissected 1 rat each per time point (n = 6 rats), completing vessel skeletonization followed by end-to-end artery/vein anastomoses. Videos were reviewed postprocedure to assess scar score and relative difficulty of dissection by blinded raters using 4-point Likert scales. RESULTS At all time points, vessels were markedly invested in friable scar, and exposure was subjectively assessed as a reasonable surrogate for sylvian fissure dissection under SAH conditions. Scar score and relative difficulty of dissection both indicated 14 days as the most challenging time point. CONCLUSIONS The authors’ experimental model of femoral vessel skeletonization, circumferential superficial soft-tissue injury, and delayed reexploration provides a novel approximation of sylvian fissure dissection and cerebrovascular bypass under SAH conditions. The optimal reexploration interval appears to be 7–14 days. To the authors’ knowledge, this is the first model of SAH simulation for microsurgical training, particularly in a live animal system.
Effect of revascularization on cognitive outcomes in intracranial steno-occlusive disease: a systematic review
Kolb, Bradley , Fadel, Hassan , Rajah, Gary , Saber, Hamidreza , Luqman, Ali, Rangel-Castilla, Leonardo , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: 2 | Pages: E14

10.3171/2018.11.focus18517 | PMID 30717064 Get It

OBJECTIVE Steno-occlusive diseases of the cerebral vasculature have been associated with cognitive decline. The authors performed a systematic review of the existing literature on intracranial steno-occlusive disease, including intracranial atherosclerosis and moyamoya disease (MMD), to determine the extent and quality of evidence for the effect of revascularization on cognitive performance. METHODS A systematic search of PubMed/MEDLINE, the Thomson Reuters Web of Science Core Collection, and the KCI Korean Journal Database was performed to identify randomized controlled trials (RCTs) in the English-language literature and observational studies that compared cognitive outcomes before and after revascularization in patients with steno-occlusive disease of the intracranial vasculature, from which data were extracted and analyzed. RESULTS Nine papers were included, consisting of 2 RCTs and 7 observational cohort studies. Results from 2 randomized trials including 142 patients with symptomatic intracranial atherosclerotic steno-occlusion found no additional benefit to revascularization when added to maximal medical therapy. The certainty in the results of these trials was limited by concerns for bias and indirectness. Results from 7 observational trials including 282 patients found some cognitive benefit for revascularization for symptomatic atherosclerotic steno-occlusion and for steno-occlusion related to MMD in children. The certainty of these conclusions was low to very low, due to both inherent limitations in observational studies for inferring causality and concerns for added risk of bias and indirectness in some studies. CONCLUSIONS The effects of revascularization on cognitive performance in intracranial steno-occlusive disease remain uncertain due to limitations in existing studies. More well-designed randomized trials and observational studies are needed to determine if revascularization can arrest or reverse cognitive decline in these patients.
Classification of Background Parenchymal Uptake on Molecular Breast Imaging Using a Convolutional Neural Network
Carter, Rickey E. , Geske, Jennifer R. , Conners, Amy Lynn , Whaley, Dana H. , Hunt, Katie N. , O’Connor, Michael K. , Rhodes, Deborah J. , O'Connor, Michael K, Hruska, Carrie B. , Carter, Rickey E , Attia, Zachi I. , Geske, Jennifer

Mayo Clinic

JCO Clinical Cancer Informatics | February 26, 2019 | Volume: No volume available | Issue: 3 | Pages: 1-11

10.1200/cci.18.00133 | PMID 30807208 Get It

PURPOSE Background parenchymal uptake (BPU), which describes the level of radiotracer uptake in normal fibroglandular tissue on molecular breast imaging (MBI), has been identified as a breast cancer risk factor. Our objective was to develop and validate a deep learning model using image convolution to automatically categorize BPU on MBI. METHODS MBI examinations obtained for clinical and research purposes from 2004 to 2015 were reviewed to classify the BPU pattern using a standardized five-category scale. Two expert radiologists provided interpretations that were used as the reference standard for modeling. The modeling consisted of training and validating a convolutional neural network to predict BPU. Model performance was summarized in data reserved to test the performance of the algorithm at the per-image and per-breast levels. RESULTS Training was performed on 24,639 images from 3,133 unique patients. The model performance on the withheld testing data (6,172 images; 786 patients) was evaluated. Using direct matching on the predicted classification resulted in an accuracy of 69.4% (95% CI, 67.4% to 71.3%), and if prediction within one category was considered, accuracy increased to 96.0% (95% CI, 95.2% to 96.7%). When considering the breast-level prediction of BPU, the accuracy remained strong, with 70.3% (95% CI, 68.0% to 72.6%) and 96.2% (95% CI, 95.3% to 97.2%) for the direct match and allowance for one category, respectively. CONCLUSION BPU provided a robust target for training a convolutional neural network. A validated computer algorithm will allow for objective, reproducible encoding of BPU to foster its integration into risk-stratification algorithms.
Perioperative Evaluation and Management of Patients With Portopulmonary Hypertension Aiming for Orthotopic Liver Transplantation
Canabal, Juan, Irefin, Samuel A., Díaz‐Gómez, José L. , Franco, Pablo Moreno , Burger, Charles D.

Mayo Clinic

Advances in Pulmonary Hypertension | February 26, 2019 | Volume: 12 | Issue: 2 | Pages: 68-74

10.21693/1933-088x-12.2.68 Get It

Background: Portopulmonary hypertension (POPH) is defined as pulmonary arterial hypertension (PAH) in the context of portal hypertension. Severe POPH has been considered an absolute contraindication of orthotopic liver transplantation (OLT).Objective: Since there are no definitive guidelines for the immediate preoperative, intraoperative, and postoperative evaluation and treatment of POPH patients, we have used published literature along with our experience to review current knowledge in this area.Summary: Moderate-to-severe POPH has important consequences in the perioperative management of candidates for OLT. Adequate right ventricular function is critical to survive the hemodynamic burden of OLT. Immediate preoperative assessment of hemodynamics; careful intraoperative monitoring and management of volume status, pressure changes, and ventricular function; and postoperative transitions of PAH-specific therapy are key components to successful OLT. We emphasize the advantages of the echocardiogram during all of these phases and stress the importance of a team approach to plan care and respond to the multiple challenges of OLT in POPH.
Preoperative Assessment and Management of Liver Transplant Candidates With Portopulmonary Hypertension
Cartin‐Ceba, Rodrigo , Krowka, Michael J.

Mayo Clinic

Advances in Pulmonary Hypertension | February 26, 2019 | Volume: 12 | Issue: 2 | Pages: 60-67

10.21693/1933-088x-12.2.60 Get It

Pulmonary artery hypertension (PAH) that occurs as a consequence of portal hypertension is termed portopulmonary hypertension (POPH) and is associated with significant morbidity and mortality. Among liver transplant (LT) candidates, reported incidence rates of POPH range from 4.5% to 8.5%. The severity of POPH is unrelated to the severity of portal hypertension or the liver disease. In LT patients, intraoperative death and immediate post-LT mortality are feared clinical events when transplantation is attempted in the setting of untreated, moderate to severe POPH. Specific pulmonary artery vasodilator medications (PAH-specific therapy) appear effective in reducing pulmonary artery pressures, improving right ventricular (RV) function and survival. Thus, screening for and accurately diagnosing POPH prior to LT has become a standard of care. The post-LT course of patients with moderate POPH is unpredictable, but most patients can be weaned from PAH-specific therapy over time. In this article, we present an overview of the preoperative assessment of POPH with an emphasis on risk assessment for transplant and the most recent medical treatment options.
PHPN: O2 Trials and Tribulations
Bartlett, Mary Lynne, Zeiger, Tonya K., Bartlett, Mary

Mayo Clinic

Advances in Pulmonary Hypertension | February 26, 2019 | Volume: 12 | Issue: 3 | Pages: 152-155

10.21693/1933-088x-12.3.152 Get It